Table 1 ERP29 rs7114 genotypes in 250 oropharynx squamous cell carcinoma and 250 controls.

From: Role of a genetic variation in the microRNA-4421 binding site of ERP29 regarding risk of oropharynx cancer and prognosis

Genotypes

OPSCC

n (%)

Controls

n (%)

OR (95% CI)

p-value

ERP29 rs7114

AA

150 (60.0)

177 (70.8)

Reference

 

AG

84 (33.6)

64 (25.6)

1.69 (0.83–3.43)

0.14

GG

16 (6.4)

9 (3.6)

5.67 (1.27–25.26)*

0.02

AA or AG

234 (93.6)

241 (96.4)

Reference

 

GG

16 (6.4)

9 (3.6)

5.50 (1.19–25.38)**

0.02

AA

150 (60.0)

177 (70.8)

Reference

 

AG or GG

100 (40.0)

73 (29.2)

2.05 (1.04–4.05)***

0.03

A allele

384 (76.8)

418 (83.6)

Reference

 

G allele

116 (23.2)

82 (16.4)

2.13 (1.20–3.78)****

0.02

  1. OPSCC oropharynx squamous cell carcinoma, n number of patients or controls, OR odds ratio adjusted by age, smoking and drinking status, CI confidence interval.
  2. The significant values are indicated by bold letters.
  3. *Power of analysis (PA): 30.0%; **PA: 30.0%; ***PA: 72.0%; ****PA: 77.1%.